With all the caveats of the proposed models, the studies performed to date indicate a possible role of endolysosomal dysfunction in LRRK2-PD, which requires further validation in more appropriate models, such as iPSCs-derived neurons or organoids from patients carrying LRRK2 mutations. This evidence concerns the gene LRRK2 and Parkinson disease.